Policy Indications: Professional College Fees Must be Non-Exploitative  |  Parent Interventions: As a Studious Girl Destroyed Her Mobile Phone  |  Teacher Insights: Know about how to choose the best MPPSC coaching institute  |  National Edu News: Swinburne University of Technology & IIT H launch the joint doctoral program  |  Policy Indications: India & Japan collaborations for innovations on Hydrogen based technologies  |  National Edu News: Education Minister addresses at the Annual Convocation of IIM Rohtak  |  Education Information: UPSC postpones tests and Interviews of some examinations  |  National Edu News: Piyush Goyal launches the Startup India Seed Fund Scheme  |  Teacher Insights: Are you Proficient in English?  |  National Edu News: National climate vulnerability assessment sees 8 states as highly vulnerable  |  National Edu News: Education minister e-launches long-lasting hygiene product DuroKea Series  |  National Edu News: Punjab’s new nutrient rich crop varieties can satisfy India's nutritional needs   |  Guest Column: Delicious Dhabas  |  International Edu News: 2D Perovskites for Solar Cells and LEDS  |  International Edu News: AI Model for Predicting Tsunami  |  
March 19, 2020 Thursday 11:37:36 AM IST

World’s first artificial pancreas app licensed for people with type 1 diabetes

International Edu News

The world’s first licensed, downloadable artificial pancreas app for people with type 1 diabetes has been launched. The app is based on over a decade of research by Professor Roman Hovorka at the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust. The CamAPS FX app works with an insulin pump and a glucose monitor to automatically deliver insulin to people living with the condition via a complex algorithm.

The app - which Professor Hovorka hopes will become available on the NHS in the future - will take over much of the management of the condition. This is particularly important at night, when many people with type 1 diabetes experience potentially dangerous low blood glucose levels. The app can also upload the user’s blood glucose measurements seamlessly to Diasend, an online platform, allowing their diabetes team to provide more personalised care.

The CamAPS FX app is backed by 13 years of clinical research carried out by Professor Hovorka and his research group at the Wellcome-MRC Institute of Metabolic Science. It is licensed for use by both adults and children with the condition and is the first artificial pancreas system to be licensed for use in pregnancy, or by young children aged one and above.

The commercial launch is a milestone in the journey towards a fully automated artificial pancreas for everyone with type 1 diabetes. Such technology will fundamentally change life with the condition by working with a range of insulin pumps and glucose monitors to lift the burden of managing a condition that is relentlessly unpredictable day and night. Professor Hovorka will continue refining the artificial pancreas through research into mealtime glucose control and improving ease of use.


The research behind the app has been funded by the type 1 diabetes charity JDRF, Diabetes UK, the National Institute for Health Research, the National Institutes of Health, Horizon 2020, and The Leona M and Harry B Helmsley Charitable Trust

The app is now available for UK users to download onto Android phones via the Amazon Appstore. The app is available on a subscription basis starting at £70 per month.


(Content Courtesy: https://www.cam.ac.uk/research/news/worlds-first-artificial-pancreas-app-licensed-for-people-with-type-1-diabetes-in-uk)



Comments